IP Library Granted Patent US 11,873,516
Granted Patent B2
US 11,873,516 · App. 17/667,379 · Granted Jan 16, 2024

Engineered polymerases for improved sequencing by binding

Inventors: Pinar Iyidogan (San Diego, CA); Mariam Iftikhar (San Diego, CA); Bridget Kidd (San Diego, CA); Lewis Churchfield (San Diego, CA)
Assignee: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
C12N9/1252
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,873,516
App. No.
17/667,379
Granted
Jan 16, 2024
Kind
B2
Abstract

Provided herein are engineered DNA polymerases comprising modifications improving accuracy and processivity of the polymerase including modifications in the Motif A region, optionally, along with additional modifications in the palm and/or exonuclease domains of the polymerase. Also provided are nucleic acids encoding the engineered DNA polymerases comprising modifications in motif A of the polymerase, optionally, with additional modifications. Methods, vectors, kits, and compositions comprising the nucleic acids and compositions, methods and kits comprising the engineered polymerases are also provided.

Claims (5)

1. An engineered DNA polymerase, wherein the DNA polymerase comprises an amino acid sequence that has at least 98% amino acid sequence identity to the amino acid sequence of SEQ ID NO:1 and comprises amino acid substitutions L408F, Y409F, P410T, M523T, V524T, L544F, and H545F, wherein amino acid numbering is relative to the amino acid sequence of SEQ ID NO:1.

2. The engineered DNA polymerase of claim 1 , wherein the polymerase has increased processivity compared to a control polymerase without the amino acid substitutions.

3. The engineered DNA polymerase of claim 2 , wherein the control polymerase comprises the amino acid sequence of SEQ ID NO:4.

4. The engineered DNA polymerase of claim 1 , wherein the polymerase comprises an alanine residue at position 141, an alanine residue at position 143, and a leucine residue at position 485, wherein amino acid numbering is relative to the amino acid sequence of SEQ ID NO:1.

5. A kit comprising the engineered polymerase of claim 1 and instructions for use.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 8, 2023
From: OMNIOME, LLC
To: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Reel/Frame 062920/0752 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2022
From: IYIDOGAN, PINAR; IFTIKHAR, MARIAM; KIDD, BRIDGET; CHURCHFIELD, LEWIS
To: OMNIOME, INC.
Reel/Frame 058932/0048 →
MERGER Recorded Feb 8, 2022
From: OMNIOME, INC.
To: OMNIOME, LLC
Reel/Frame 058932/0117 →
Continuity (3)
Continuation 17091998 · Nov 6, 2020
Provisional Application 62933073 · Nov 8, 2019
Related Publication 20220235338A1 · Jul 28, 2022